Bio-Rad

The firm plans to stay the course on its long-term company transformation goals despite the imminent departure of its chief financial officer, one of the plan's architects.

New data has demonstrated that DNA fragment size differences that discriminate preeclampsia from healthy controls can be detected using a lower-cost PCR method.

The company's Life Sciences segment revenues fell 7 percent, while Clinical Diagnostic revenues rose 3 percent.